Description
Recombinant monoclonal antibody to CD96. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BL006-19-29G5-29K1.
Target
CD96
Target Alias Names
Tactile, T cell activation, increased late expression, Cluster of Differentiation 96
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression